SCHEMBL5165

SCHEMBL5165

COCCc1ccc(N2CCC3(CCC(O)(CC(C)C)CC3)C2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 8/20 0.37
CYP2C19 P33261 3/20 0.37
TSHR P16473 2/20 0.37
USP2 O75604 3/20 0.37
ALDH1A1 P00352 3/20 0.37
HSD17B10 Q99714 3/20 0.37
CYP1A2 P05177 3/20 0.37
CYP2C9 P11712 3/20 0.37
HPGD P15428 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
S1PR1 P21453 1/20 0.36
RORC P51449 4/20 0.36
MAPK1 P28482 2/20 0.35
ACACB O00763 1/20 0.35
KCNH2 Q12809 1/20 0.34
ALOX15 P16050 1/20 0.34
HIF1A Q16665 1/20 0.34
CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5166 1.00 CYP3A4 (0.37) CYP3A4CYP2C19TSHRUSP2ALDH1A1
SCHEMBL5639 0.85 S1PR1 (0.41) CYP3A4CYP2C19TSHRUSP2ALDH1A1
SCHEMBL5214 0.80 S1PR1 (0.40) CYP3A4CYP2C19TSHRUSP2ALDH1A1
SCHEMBL12702132 0.76 LIPE (0.51) S1PR1
SCHEMBL1589104 0.76 LIPE (0.51) S1PR1
SCHEMBL5655 0.75 CYP3A4 (0.40) CYP3A4CYP2C19TSHRUSP2ALDH1A1
SCHEMBL5611 0.74 CYP3A4 (0.40) CYP3A4CYP2C19TSHRUSP2ALDH1A1
SCHEMBL5546 0.72 LIPE (0.44) CYP3A4CYP2C19TSHRUSP2ALDH1A1
SCHEMBL4962 0.70 RYR2 (0.41) CYP3A4CYP2C19TSHRUSP2ALDH1A1
SCHEMBL5834 0.70 S1PR1 (0.37) CYP3A4CYP2C19TSHRUSP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed